These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9323455)
1. Buspirone potentiation of antidepressants in the treatment of PTSD. Hamner M; Ulmer H; Horne D Depress Anxiety; 1997; 5(3):137-9. PubMed ID: 9323455 [No Abstract] [Full Text] [Related]
2. Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report. Khawaja IS; Hurwitz TD; Schenck CH J Clin Psychiatry; 2008 Dec; 69(12):1982-3. PubMed ID: 19203482 [No Abstract] [Full Text] [Related]
3. Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence. Sprenger D J Clin Psychopharmacol; 1997 Oct; 17(5):425-6. PubMed ID: 9315996 [No Abstract] [Full Text] [Related]
6. [The current concept of augmentation of treatment efficiency with antidepressant medication]. Damulin IV; Suvorova IA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):106-112. PubMed ID: 26171486 [TBL] [Abstract][Full Text] [Related]
7. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1997 Apr; 39(998):33-40. PubMed ID: 9109832 [No Abstract] [Full Text] [Related]
8. An open study of buspirone augmentation of neuroleptics in patients with schizophrenia. Sirota P; Epstein B; Benatov R; Sousnostzky M; Kindler S J Clin Psychopharmacol; 2001 Aug; 21(4):454-5. PubMed ID: 11476132 [No Abstract] [Full Text] [Related]
9. Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial. Duffy JD; Malloy PF Ann Clin Psychiatry; 1994 Mar; 6(1):33-7. PubMed ID: 7951643 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive risperidone treatment in combat veterans with chronic PTSD. David D; De Faria L; Lapeyra O; Mellman TA J Clin Psychopharmacol; 2004 Oct; 24(5):556-9. PubMed ID: 15349018 [No Abstract] [Full Text] [Related]
11. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522 [TBL] [Abstract][Full Text] [Related]
12. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia. Van Ameringen M; Mancini C; Wilson C J Affect Disord; 1996 Jul; 39(2):115-21. PubMed ID: 8827420 [TBL] [Abstract][Full Text] [Related]
13. Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression. Fischer P; Tauscher J; Küfferle B; Kasper S Int Clin Psychopharmacol; 1998 Mar; 13(2):83-6. PubMed ID: 9669189 [TBL] [Abstract][Full Text] [Related]
14. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report. Albayrak Y; Ekinci O Clin Neuropharmacol; 2011; 34(4):137-8. PubMed ID: 21768799 [TBL] [Abstract][Full Text] [Related]
15. Serotonin syndrome after sertraline, buspirone and loxapine? Bonin B; Vandel P; Vandel S; Sechter D; Bizouard P Therapie; 1999; 54(2):269-71. PubMed ID: 10394270 [No Abstract] [Full Text] [Related]
16. [Anxiety associated with substance abuse]. Sivolap YP Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):3-8. PubMed ID: 28300806 [TBL] [Abstract][Full Text] [Related]
17. Depression & anxiety: readers reveal the therapists and drugs that helped. Consum Rep; 2010 Jul; 75(7):28-31. PubMed ID: 20578337 [No Abstract] [Full Text] [Related]
18. Pharmacologic treatment of anxiety disorders in children and adolescents. Velosa JF; Riddle MA Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):119-33. PubMed ID: 10674193 [TBL] [Abstract][Full Text] [Related]
19. Neonatal morbidity due to maternal use of two antidepressant drugs. Jwa S; Wada Y; Yamamoto M; Sumida Y Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219 [No Abstract] [Full Text] [Related]